| Medical treatment of male infertility. | |
| | |
MedLine Citation:
|
PMID: 21117930 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Although male factors contribute to approximately half of all cases of infertility, no specific cause can be found to explain the majority of abnormalities found in semen parameters. Specific and effective medical treatment is restricted to rare endocrine disorders. As a consequence, various empirical medical treatments are often used to treat idiopathic male infertility, with limited success. This review focuses on the rationale and current evidence on the efficacy of medical treatment of male infertility. Unless new studies provide high quality evidence in favour of medical treatment, assisted reproductive technologies will remain the mainstay of treatment of male infertility. |
| | |
Authors:
|
Vivian Rittenberg; Tarek El-Toukhy |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Human fertility (Cambridge, England) Volume: 13 ISSN: 1742-8149 ISO Abbreviation: Hum Fertil (Camb) Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2010-12-01 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100888143 Medline TA: Hum Fertil (Camb) Country: England |
Other Details:
|
Languages: eng Pagination: 208-16 Citation Subset: IM |
Affiliation:
|
Assisted Conception Unit, Guy's and St Thomas' Hospital NHS Foundation Trust, London, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Clinical implications of sperm DNA damage.
Next Document: The role of antioxidant therapy in the treatment of male infertility.